Harvard Bioscience, Inc.
HBIO
$7.08
$0.111.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.50M | 7.10M | 8.61M | 6.82M | 7.44M |
| Total Receivables | 14.50M | 14.57M | 16.04M | 12.11M | 11.94M |
| Inventory | 22.23M | 22.21M | 20.81M | 21.60M | 22.26M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.23M | 3.60M | 2.76M | 3.28M | 3.34M |
| Total Current Assets | 46.46M | 47.48M | 48.23M | 43.81M | 44.97M |
|
|
|||||
| Total Current Assets | 46.46M | 47.48M | 48.23M | 43.81M | 44.97M |
| Net Property, Plant & Equipment | 11.75M | 11.60M | 11.96M | 12.49M | 12.04M |
| Long-term Investments | 9.33M | 9.37M | 9.56M | 9.53M | 10.15M |
| Goodwill | 9.33M | 9.37M | 9.56M | 9.53M | 10.15M |
| Total Other Intangibles | 6.22M | 6.91M | 7.64M | 8.38M | 9.14M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.53M | 2.58M | 2.69M | 3.79M | 3.79M |
| Total Assets | 76.29M | 77.94M | 80.07M | 77.99M | 80.09M |
|
|
|||||
| Total Accounts Payable | 6.22M | 5.29M | 3.65M | 5.18M | 4.72M |
| Total Accrued Expenses | 2.76M | 2.98M | 3.56M | 2.34M | 2.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.60M | 1.55M | 1.53M | 35.45M | 36.32M |
| Total Finance Division Other Current Liabilities | 14.22M | 14.04M | 13.23M | 11.43M | 11.33M |
| Total Other Current Liabilities | 14.22M | 14.04M | 13.23M | 11.43M | 11.33M |
| Total Current Liabilities | 24.79M | 23.86M | 21.96M | 54.40M | 55.20M |
|
|
|||||
| Total Current Liabilities | 24.79M | 23.86M | 21.96M | 54.40M | 55.20M |
| Long-Term Debt | 36.68M | 36.21M | 35.87M | -- | 44.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.93M | 6.36M | 6.88M | 7.33M | 7.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.47M | 1.46M | 1.63M | 2.20M | 2.12M |
| Total Liabilities | 68.87M | 67.89M | 66.34M | 63.92M | 64.36M |
|
|
|||||
| Common Stock & APIC | 240.84M | 240.49M | 240.12M | 238.37M | 238.07M |
| Retained Earnings | -221.04M | -218.13M | -214.71M | -211.86M | -210.63M |
| Treasury Stock & Other | -12.38M | -12.31M | -11.67M | -12.44M | -11.70M |
| Total Common Equity | 7.42M | 10.05M | 13.73M | 14.07M | 15.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.42M | 10.05M | 13.73M | 14.07M | 15.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.42M | 10.05M | 13.73M | 14.07M | 15.73M |
|
|
|||||